March 28, 2024
Texas CARES researchers observed the prozone effect — very high (strongly positive) antibody levels that test as weakly positive — on some S-test results. Their findings were published in PLOS ONE.
November 29, 2023
The Texas CARES team provided an update to previous findings covering breakthrough COVID-19 infections in a letter to the editor published in Open Forum Infectious Diseases.
October 24, 2023
Children had antibodies from a COVID-19 infection or vaccination for up to 12 months, suggesting they may have some protection from the virus for at least a year, according to new findings from UTHealth Houston researchers.
October 24, 2023
The Texas CARES team examined now long antibodies last in children and adolescents. Findings were published in the journal Pediatric Research.
April 30, 2023
Texas CARES researchers analyzed COVID-19 variant symptoms among Texas CARES participants ages 5-19. Their findings were published in Children by MDPI.
February 7, 2023
Breakthrough COVID-19 infections after vaccination occurred in 7.5% of Texans surveyed, and higher odds were associated with Hispanic ethnicity, larger household size, rural versus urban living, type of vaccination, and multiple comorbidities, according to findings from UTHealth Houston School of Public Health, published Feb. 2 in the Journal of Infectious Diseases.
February 2, 2023
Texas CARES researchers analyzed breakthrough COVID-19 infections after vaccination among Texas CARES participants. Their findings were published in The Journal of Infectious Diseases.
November 1, 2022
The National Geographic cited the Texas CARES article “Comparison of Persistent Symptoms Following SARS-CoV-2 Infection by Antibody Status in Nonhospitalized Children and Adolescents” in its recent look at long COVID in children around the world.
September 12, 2022
Public health and safety strategies are only as effective as the information that guides them. Researchers and scientists at UTHealth Houston and the Texas Department of State Health Services (DSHS) developed a more accurate way to estimate the percentage of community members with some level of protection from antibodies developed in response to COVID-19 infection or vaccination. These findings could help shape public pandemic preparedness both now and in the future.
September 9, 2022
Texas CARES researchers determined a way to estimate antibodies to COVID-19 infections and COVID-19 vaccinations in people living in a large region. The findings were published in PLOS ONE.
